Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

A description of the content follows : If you follow the advice or stock market researcgh firms like Jeffries or Credit Suisse, you may not want to. A quick look at bad ratings for Tenet Healthcare (THC) only scratches the surface of poor equity research.

Search SCN
Sign-Up For Our
Free Newsletter
RSS

Add to Google

Blog Counter

Small Cap Network Blog

2/27/2008

Tenet Healthcare (THC) Jumps Again…Important Lesson Learned

Filed under: — SmallCapNetwork Editor @ 9:44 am

We didn’t even get a chance to celebrate yesterday’s victory with our Tenet Healthcare (NYSE: THC) pick before we got another one today. THC shares are up another 7% following yesterday’s 14.5% rally. That’s a 22.5% romp in less than 48 hours.

What causes this kind of bullish volatility just a day after a giant surge? Let’s just call it the fallout from Tenet’s good news. A lot of pessimistic analysts were caught with their pants down…they were bearish on the stock, and the company embarrassed their stock forecasting skills. Like cockroaches scurrying when the lights are flipped on (sorry…disgusting analogy, but true), all these firms are scrambling to update their opinions.

Just today, Jeffries raised their opinion to a “hold’, and Credit Suisse raised their rating to a ‘neutral’ (from underperform). I suspect we’ll see a few more stragglers submit new ratings later on this week.

First of all, a rhetorical question…what good does it do you to follow Jeffries or Credit Suisse advice if all they’re doing is responding to the same news (after the fact, no less) you and I are getting? Their tardiness left their fans holding the bag - or missing the boat - yesterday.

Second, my key point…evidenced by the previous question.

Some big-name research is good; most of it is crap. Tenet Healthcare’s a great example of how worthless many of these high-profile research outfits are.

On the chart below we’ve logged most of the key ratings changes for Tenet. Upgrades are marked with green arrows; downgrades are marked with red arrows. See if you spot the problem with the practice.

Some of the pick points were quite good. Most were not.

It’s also worth noting that the chart may be a little too deceptive in favor or the analysts. What appears to be upgrades in front of rallies or downgrades in front of plunges are actually rallies and plunges CAUSED BY the ratings change. Those weren’t actionable by the average investor - the move had already happened by the time the new rating was publicized.

Of the 16 opinion changes we see here, only eight of them were of any use to you and I. The other eight were late, or plain-old wrong.

I don’t know how you feel, but if my odds are just as good with a coin toss, I’ll do my own research and form my own opinion thank you very much.

By the way, the timing of the analyst ratings for Tenet were actually better than average. Scary.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Comments »

No comments yet.

RSS feed for comments on this post.

Leave a comment

Line and paragraph breaks automatic, e-mail address never displayed, HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>